Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0XT8W
|
|||
| Drug Name |
SOM3355
|
|||
| Indication | Huntington disease [ICD-11: 8A01.10; ICD-10: G10; ICD-9: 294.1, 333.4] | Phase 2 | [1] | |
| Tardive dyskinesia [ICD-11: 8A02.10] | Phase 1 | [2] | ||
| Company |
SOM Biotech Cambridge, MA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03575676) Efficacy and Safety of SOM3355 in Huntington's Disease Chorea. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.